Why the study?
Do new oral anticoagulants prevent second stroke in patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack compared to warfarin?
Population
Patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack
Comparison
New oral anticoagulants vs Warfarin
Design
Guideline
Authors
Loading...
Supports NOAC preference for secondary prevention in nonvalvular AF with prior stroke/TIA; extends trial evidence into updated guidelines.
Do new oral anticoagulants prevent second stroke in patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack compared to warfarin?
This executive summary provides updated Korean clinical practice guidelines for the use of new oral anticoagulants versus warfarin in patients with nonvalvular atrial fibrillation and prior ischemic stroke or TIA.
Jung et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: